Enovix director granted 29,104 RSUs in Form 4

GUTMANN BERNARD reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GUTMANN BERNARD reported acquisition or exercise transactions in this Form 4 filing.

Enovix Corp director Bernard Gutmann received a grant of 29,104 restricted stock units (RSUs) on common stock as compensation. The RSUs vest in four equal installments on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholder meeting date, subject to continued service. After this award, Gutmann holds 99,063 shares in total, including 30,766 shares issuable upon settlement of existing RSUs.

Insider Trade Summary

Grant/Award: 29,104 shares

Grant/Award 1 txn

Insider GUTMANN BERNARD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,104	$0.00	$0.00

Holdings After Transaction: Common Stock — 99,063 shares (Direct)

Footnotes (2)

1. F1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
2. F2. Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Key Figures

RSUs granted: 29,104 RSUs Grant price per RSU: $0.0000 per unit Total holdings after grant: 99,063 shares +5 more

8 metrics

RSUs granted 29,104 RSUs Grant to director Bernard Gutmann on June 11, 2026

Grant price per RSU $0.0000 per unit Stated transaction price for RSU award

Total holdings after grant 99,063 shares Reported Enovix holdings following the RSU award

Existing RSUs included 30,766 shares Shares issuable upon settlement of previously granted RSUs

First vesting date September 11, 2026 25% of RSUs vest

Second vesting date December 11, 2026 Next 25% of RSUs vest

Third vesting date March 11, 2027 Next 25% of RSUs vest

Final vesting date Earlier of June 11, 2027 or 2027 meeting Final 25% of RSUs vest

Key Terms

restricted stock units ("RSUs"), contingent right, vest, settlement of RSUs

4 terms

restricted stock units ("RSUs") financial

"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vest financial

"25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settlement of RSUs financial

"Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enovix (ENVX) director Bernard Gutmann report?

Bernard Gutmann reported receiving 29,104 restricted stock units (RSUs) of Enovix common stock as a grant. This is a compensation-related equity award, not an open-market share purchase or sale, and increases his total reported holdings to 99,063 shares.

How do the new Enovix (ENVX) RSUs granted to Bernard Gutmann vest?

The 29,104 RSUs granted to Bernard Gutmann vest in four equal parts. Vesting dates are September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholder meeting date, subject to continuous service.

Is Bernard Gutmann’s Enovix (ENVX) Form 4 transaction a stock purchase or sale?

The Form 4 reports an equity grant, not a market trade. Gutmann acquired 29,104 RSUs at a stated price of $0.0000 per unit, reflecting a compensation award rather than a cash purchase or sale of Enovix common stock in the open market.

What are Bernard Gutmann’s total Enovix (ENVX) holdings after this Form 4?

Following the RSU grant, Bernard Gutmann is reported to hold 99,063 Enovix shares. This total includes 30,766 shares issuable upon settlement of previously granted RSUs, in addition to the newly awarded 29,104 RSUs disclosed in the filing.

What does each Enovix (ENVX) RSU granted to Bernard Gutmann represent?

Each RSU represents a contingent right to receive one share of Enovix common stock upon settlement. The units convert into shares only as they vest over time, provided Gutmann continues to serve as a director through the respective vesting dates.

Are there conditions attached to Bernard Gutmann’s Enovix (ENVX) RSU vesting?

Yes. Vesting of the RSUs is conditioned on Gutmann’s continuous service as a director through each vesting date. The final tranche vests on the earlier of June 11, 2027 or the date immediately before the 2027 annual meeting if his service ends then.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 09:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GUTMANN BERNARD

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W WARREN AVENUE

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		29,104(1)	A	$0	99,063(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.

2. Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Bernard Gutmann	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)